August 5, 2025

NewAmsterdam Pharma (NAMS): Unveiling a 91.71% Potential Upside with Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing the attention of investors with its promising growth trajectory in the healthcare sector, specifically within the biotechnology industry...

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 254% Potential Upside

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotech firm headquartered in Waltham, Massachusetts, is drawing significant attention in the healthcare sector with its innovative approach to..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Giant with 177% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a key player in the healthcare sector, has been capturing significant investor attention due to its robust growth prospects and compelling..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 51.62% Potential Upside for Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its robust growth potential and promising market position. Headquartered in Eagle, Idaho,..

Organon & Co. (OGN) Stock Analysis: Unlocking a Potential 37.88% Upside for Investors

Investors with an eye on the healthcare sector might find Organon & Co. (OGN) an intriguing opportunity as the company’s stock presents a potential upside of..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 26% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings Signal 24% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is making waves in the biopharmaceutical sector, capturing investor attention with a robust growth trajectory and an impressive forecasted upside. With..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 178% Potential Upside with Innovative Cardiorenal Solutions

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to tackling cardiorenal diseases...

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Uncovering a 31.51% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing investor attention with its promising prospects in the biotechnology industry. With a market capitalization of $2.59 billion, this Foster..

Innoviva, Inc. (INVA) Stock Analysis: A Potential 116.96% Upside with Robust Revenue Growth

Innoviva, Inc. (NASDAQ: INVA) operates within the dynamic healthcare sector, focusing on biotechnology, where it engages in the development and commercialization of a broad range of..

Disc Medicine, Inc. (IRON): Analyst Consensus Highlights 62.65% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its promising growth potential and a robust pipeline of treatments aimed at serious hematologic..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

Immunovant, Inc. (IMVT) Stock Analysis: Understanding the 158.81% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and remarkable potential upside. With..

Evolent Health, Inc (EVH) Stock Analysis: Navigating a Potential 56.68% Upside in Healthcare Innovation

Evolent Health, Inc. (NASDAQ: EVH), a prominent player in the healthcare sector, is making waves in the Health Information Services industry with its innovative approaches to..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analysts Predict a 48.88% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, has garnered significant attention from investors..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 50% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, presents an intriguing opportunity for..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the Highs of Revenue Growth Amidst Market Challenges

Ascentage Pharma Group International (AAPG), a key player in the biotechnology sector, is gaining attention with its remarkable revenue growth of 97.90%. Specializing in developing therapies..

Kymera Therapeutics (KYMR) Stock Analysis: A Biotech Powerhouse with 38% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering name in the biotechnology industry, is making waves with its promising portfolio of small molecule therapeutics. Specializing in leveraging..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 95% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the medical devices industry, is capturing investor attention with its impressive potential upside of 95.53%, according to analyst..

Mesoblast Limited (MESO): Investor Outlook on a Biotech with Promising Upside Potential

Mesoblast Limited (MESO), a key player in the biotechnology sector, has been turning heads with its compelling growth potential, notably boasting a substantial 74.98% potential upside,..

Search

Funds

August 5, 2025

Search

Funds

August 5, 2025

FTSE 100

Funds